跳至主要内容
临床试验/CTRI/2024/06/069653
CTRI/2024/06/069653尚未招募3 期

Efficacy of topical heparin in preventing superficial thrombophlebitis after peripheral intravenous cannulation: A placebo controlled randomized trial - NI

All India Institute of Medical Sciences, Mangalagiri0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Children aged 1 month-14 years admitted in inpatient department requiring IV cannulation for at least 72 hours
  • 2.Parents who have given written informed consent

排除标准

  • Children who required iv access in the last 28 days, have hypersensitivity to heparin, have any condition which has procoagulant tendency, already on anticoagulant therapy or planned for anti coagulant therapy, already on non-steroidal anti-inflammataory drugs or planned for non-steroidal anti-inflammataory drugs

研究者

相似试验